193 related articles for article (PubMed ID: 23103620)
1. Population pharmacokinetics of lamotrigine in Chinese children with epilepsy.
He DK; Wang L; Qin J; Zhang S; Lu W; Li L; Zhang JM; Bao WQ; Song XQ; Liu HT
Acta Pharmacol Sin; 2012 Nov; 33(11):1417-23. PubMed ID: 23103620
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
[TBL] [Abstract][Full Text] [Related]
3. [Population pharmacokinetics of lamotrigine in Chinese children with epilepsy].
Zhang S; Wang L; Lu W
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Apr; 10(2):105-9. PubMed ID: 18433522
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic models of lamotrigine in different age groups of Chinese children with epilepsy.
Zhang ZB; Ji SM; Han Y; Zang LL; Wang YH; Lu W; Wang L; Wu Y
Eur J Clin Pharmacol; 2017 Apr; 73(4):445-453. PubMed ID: 28064355
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy.
Rivas N; Buelga DS; Elger CE; Santos-Borbujo J; Otero MJ; Domínguez-Gil A; García MJ
Ther Drug Monit; 2008 Aug; 30(4):483-9. PubMed ID: 18641550
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy.
Peng J; Zhang HN; Liu ZS; Xu H; Wang Y
Int J Clin Pharmacol Ther; 2014 Aug; 52(8):684-92. PubMed ID: 24887335
[TBL] [Abstract][Full Text] [Related]
7. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.
Gidal BE; Anderson GD; Rutecki PR; Shaw R; Lanning A
Epilepsy Res; 2000 Nov; 42(1):23-31. PubMed ID: 10996503
[TBL] [Abstract][Full Text] [Related]
8. A Population Pharmacokinetic-Pharmacogenetic Model of Lamotrigine in Chinese Children With Epilepsy.
Chen Y; Xu S; Wang Z; Zhao M; Wang H; Lu T; Zhao L
Ther Drug Monit; 2018 Dec; 40(6):730-737. PubMed ID: 30169477
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine and valproate pharmacokinetics interactions in epileptic patients.
Lalic M; Cvejic J; Popovic J; Bozic K; Golocorbin-Kon S; Al-Salami H; Mikov M
Eur J Drug Metab Pharmacokinet; 2009; 34(2):93-9. PubMed ID: 19645218
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of valproate in Chinese children with epilepsy.
Jiang DC; Wang L; Wang YQ; Li L; Lu W; Bai XR
Acta Pharmacol Sin; 2007 Oct; 28(10):1677-84. PubMed ID: 17883957
[TBL] [Abstract][Full Text] [Related]
11. The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy.
Han X; Huang J; Lv J; Ma L; Peng L; Wang J; Nie X; Xia L; Zan X
PLoS One; 2019; 14(1):e0210600. PubMed ID: 30645607
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of lamotrigine in paediatric and young adult epileptic patients--nonlinear mixed effects modelling approach.
Brzaković B; Vučićević K; Kovačević SV; Miljković B; Prostran M; Martinović Ž; Pokrajac M
Eur J Clin Pharmacol; 2014 Feb; 70(2):179-85. PubMed ID: 24240511
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy.
Chen CY; Zhou Y; Cui YM; Yang T; Zhao X; Wu Y
J Clin Pharm Ther; 2019 Apr; 44(2):300-311. PubMed ID: 30636182
[TBL] [Abstract][Full Text] [Related]
14. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine.
Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y
Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295
[TBL] [Abstract][Full Text] [Related]
15. Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service.
Morris RG; Black AB; Harris AL; Batty AB; Sallustio BC
Br J Clin Pharmacol; 1998 Dec; 46(6):547-51. PubMed ID: 9862243
[TBL] [Abstract][Full Text] [Related]
16. Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy.
Inoue K; Yamamoto Y; Suzuki E; Takahashi T; Umemura A; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
Eur J Clin Pharmacol; 2016 May; 72(5):555-62. PubMed ID: 26790665
[TBL] [Abstract][Full Text] [Related]
17. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
[TBL] [Abstract][Full Text] [Related]
18. Saliva and serum concentration of lamotrigine in patients with epilepsy.
Tsiropoulos I; Kristensen O; Klitgaard NA
Ther Drug Monit; 2000 Oct; 22(5):517-21. PubMed ID: 11034255
[TBL] [Abstract][Full Text] [Related]
19. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.
Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y
Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.
Eriksson AS; Hoppu K; Nergårdh A; Boreus L
Epilepsia; 1996 Aug; 37(8):769-73. PubMed ID: 8764817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
